Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RISANKIZUMAB vs RITALIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RISANKIZUMAB vs RITALIN: Safety Overview

Metric RISANKIZUMAB RITALIN
Total FAERS Reports 2,642 123
Deaths Reported 41 7
Death Rate 1.6% 5.7%
Hospitalizations 439 23
Average Patient Age 52.1 yrs 27.5 yrs
% Female Patients 51.3% N/A
Manufacturer AbbVie Inc. N/A
Route SUBCUTANEOUS N/A